C57BL/6NCya-Maptem1/Cya
Common Name
Mapt-KO
Product ID
S-KO-03270
Backgroud
C57BL/6NCya
Strain ID
KOCMP-17762-Mapt-B6N-VA
When using this mouse strain in a publication, please cite “Mapt-KO Mouse (Catalog S-KO-03270) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Mapt-KO
Strain ID
KOCMP-17762-Mapt-B6N-VA
Gene Name
Product ID
S-KO-03270
Gene Alias
Tau, Mtapt, PHF-tau
Background
C57BL/6NCya
NCBI ID
Modification
Conventional knockout
Chromosome
Chr 11
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000100347
NCBI RefSeq
NM_001038609
Target Region
Exon 8
Size of Effective Region
~0.3 kb
Overview of Gene Research
Mapt, encoding the microtubule-associated protein tau, is crucial for maintaining microtubule function and axonal transport. Tau is mainly expressed in neurons, participating in axonal transport and synaptic plasticity. Six major isoforms of tau are generated by alternative splicing of MAPT transcripts, which is regulated spatially and developmentally [2,3].
In mouse models, humanizing the entire murine Mapt gene (by replacing it with the human ortholog) created a platform to study human tauopathy. The double-knock-in mice (MAPT and App) exhibited higher tau phosphorylation. Tau humanization significantly accelerated cell-to-cell propagation of AD brain-derived pathological tau, with Aβ-amyloidosis intensifying tau accumulation [1]. Mutations in MAPT, like ∆K281, can cause Pick's disease, characterized by numerous inclusions of hyperphosphorylated 3R Tau in neurons and glial cells [5]. Also, MAPT haplotypes, such as H1G, are associated with an increased risk of dementia with Lewy bodies [4].
In conclusion, Mapt is essential for microtubule-related functions in neurons. Model-based research, especially the humanized Mapt mouse model, has revealed its role in tauopathy and neurodegenerative diseases like Alzheimer's, Pick's disease, and dementia with Lewy bodies. Understanding Mapt's functions and its genetic variations provides insights into the pathogenesis of these diseases, potentially guiding the development of targeted therapies.
References:
1. Saito, Takashi, Mihira, Naomi, Matsuba, Yukio, Trojanowski, John Q, Saido, Takaomi C. 2019. Humanization of the entire murine Mapt gene provides a murine model of pathological human tau propagation. In The Journal of biological chemistry, 294, 12754-12765. doi:10.1074/jbc.RA119.009487. https://pubmed.ncbi.nlm.nih.gov/31273083/
2. Corsi, Andrea, Bombieri, Cristina, Valenti, Maria Teresa, Romanelli, Maria Grazia. 2022. Tau Isoforms: Gaining Insight into MAPT Alternative Splicing. In International journal of molecular sciences, 23, . doi:10.3390/ijms232315383. https://pubmed.ncbi.nlm.nih.gov/36499709/
3. Ruiz-Gabarre, Daniel, Carnero-Espejo, Almudena, Ávila, Jesús, García-Escudero, Vega. 2022. What's in a Gene? The Outstanding Diversity of MAPT. In Cells, 11, . doi:10.3390/cells11050840. https://pubmed.ncbi.nlm.nih.gov/35269461/
4. Labbé, Catherine, Heckman, Michael G, Lorenzo-Betancor, Oswaldo, Dickson, Dennis W, Ross, Owen A. 2016. MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies. In Alzheimer's & dementia : the journal of the Alzheimer's Association, 12, 1297-1304. doi:10.1016/j.jalz.2016.05.002. https://pubmed.ncbi.nlm.nih.gov/27287057/
5. Schweighauser, Manuel, Garringer, Holly J, Klingstedt, Therése, Ghetti, Bernardino, Newell, Kathy L. 2023. Mutation ∆K281 in MAPT causes Pick's disease. In Acta neuropathologica, 146, 211-226. doi:10.1007/s00401-023-02598-6. https://pubmed.ncbi.nlm.nih.gov/37351604/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
